Earlier this week, the Federal Court granted Astrazeneca’s order prohibiting the Minister of Health from issuing a notice of compliance to R... Read more »
Astrazeneca Canada Inc. v. Ranbaxy Pharmaceuticals Canada Inc.: Not So "Obvious to Try"
Earlier this week, the Federal Court granted Astrazeneca’s order prohibiting the Minister of Health from issuing a notice of compliance to R... Read more »
The Federal Court released a decision to dismiss an application under the provisions of the Patented Medicines (Notice of Compliance) Regula... Read more »
The BIO 2013 International Convention takes place April 22 - 25, 2013 in Chicago, Illinois. This is one of the biggest and most attended con... Read more »
The Federal Court of Appeal has affirmed Justice Hughes’ May 11, 2012 judgement in APOTEX INC. v ASTRAZENECA CANADA INC. (2012 FC 559) where... Read more »
Canadian intellectual property practitioners were slightly surprised on March 1, 2013 with a new bill titled “Bill C-56 – the Combating Coun... Read more »
The always-informative Patently-O blog recently posted an article titled “ 10 Secrets to Locating Non-Patent Prior Art .” We thought this w... Read more »
The Canadian Intellectual Property Office ( CIPO ) recently released a report entitled “ Report on the Patent Prosecution Highway (PPH) Prog... Read more »
In a decision released last month, Judge Snider illustrated that sometimes electing to not make a decision is in fact the best decision. A l... Read more »
The Federal Court released a decision (2013 FC 141) last month affirming the validity of the patent covering the active ingredient of GLEEVE... Read more »
This is the second part of a two part series by Dr. Euan Taylor. Read the first post, Intellectual Property Due Diligence - The Basics (Part... Read more »